Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial
2024 · The Lancet · 106 citations
https://doi.org/10.1016/s0140-6736(24)00921-8
W
Wyllians Vendramini Borelli
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
150
Papers
897
Citations
14
h-index
25
i10-index
Wyllians Vendramini Borelli is an academic researcher from Universidade Federal do Rio Grande do Sul. The author has contributed to research in topics: Dementia and Cognitive Impairment Research & Alzheimer's disease research and treatments & Functional Brain Connectivity Studies. The author has an h-index of 14, co-authored 128 publications.
ORCID: 0000-0001-9282-0601Papers by this author
worksThe next pandemic: impact of COVID-19 in mental healthcare assistance in a nationwide epidemiological study
2021 · The Lancet Regional Health - Americas · 73 citations
https://doi.org/10.1016/j.lana.2021.100061
Preventable risk factors of dementia: Population attributable fractions in a Brazilian population-based study
2022 · The Lancet Regional Health - Americas · 45 citations
https://doi.org/10.1016/j.lana.2022.100256
Subjective cognitive decline in Brazil: Prevalence and association with dementia modifiable risk factors in a population‐based study
2022 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 14 citations
https://doi.org/10.1002/dad2.12368
Microglia modulate Aβ-dependent astrocyte reactivity in Alzheimer’s disease
2025 · Nature Neuroscience · 6 citations
https://doi.org/10.1038/s41593-025-02103-0
Prevalence, distribution and future projections of Parkinson disease in Brazil: insights from the ELSI-Brazil cohort study
2025 · The Lancet Regional Health - Americas · 5 citations
https://doi.org/10.1016/j.lana.2025.101046
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat